Taiwan · Delayed Price · Currency is TWD Anxo Pharmaceutical Statistics
Total Valuation
TPEX:6677 has a market cap or net worth of TWD 1.06 billion. The enterprise value is 1.46 billion.
| Market Cap | 1.06B |
| Enterprise Value | 1.46B |
Important Dates
The next estimated earnings date is Wednesday, May 13, 2026.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:6677 has 55.87 million shares outstanding. The number of shares has increased by 2.25% in one year.
| Current Share Class | 55.87M |
| Shares Outstanding | 55.87M |
| Shares Change (YoY) | +2.25% |
| Shares Change (QoQ) | +0.15% |
| Owned by Insiders (%) | 4.05% |
| Owned by Institutions (%) | 9.53% |
| Float | 28.15M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.25 |
| PB Ratio | 0.95 |
| P/TBV Ratio | 1.11 |
| P/FCF Ratio | 138.96 |
| P/OCF Ratio | 19.08 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 44.95, with an EV/FCF ratio of 192.30.
| EV / Earnings | -42.81 |
| EV / Sales | 1.73 |
| EV / EBITDA | 44.95 |
| EV / EBIT | n/a |
| EV / FCF | 192.30 |
Financial Position
The company has a current ratio of 1.57, with a Debt / Equity ratio of 0.61.
| Current Ratio | 1.57 |
| Quick Ratio | 1.07 |
| Debt / Equity | 0.61 |
| Debt / EBITDA | 20.80 |
| Debt / FCF | 89.01 |
| Interest Coverage | -2.63 |
Financial Efficiency
Return on equity (ROE) is -3.13% and return on invested capital (ROIC) is -3.15%.
| Return on Equity (ROE) | -3.13% |
| Return on Assets (ROA) | -1.31% |
| Return on Invested Capital (ROIC) | -3.15% |
| Return on Capital Employed (ROCE) | -2.86% |
| Weighted Average Cost of Capital (WACC) | 4.64% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.40 |
| Inventory Turnover | 2.10 |
Taxes
| Income Tax | -10.47M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +11.18% in the last 52 weeks. The beta is 0.38, so TPEX:6677's price volatility has been lower than the market average.
| Beta (5Y) | 0.38 |
| 52-Week Price Change | +11.18% |
| 50-Day Moving Average | 19.74 |
| 200-Day Moving Average | 21.15 |
| Relative Strength Index (RSI) | 44.44 |
| Average Volume (20 Days) | 118,789 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6677 had revenue of TWD 843.26 million and -34.13 million in losses. Loss per share was -0.61.
| Revenue | 843.26M |
| Gross Profit | 300.18M |
| Operating Income | -43.69M |
| Pretax Income | -45.60M |
| Net Income | -34.13M |
| EBITDA | 32.51M |
| EBIT | -43.69M |
| Loss Per Share | -0.61 |
Balance Sheet
The company has 387.38 million in cash and 676.37 million in debt, with a net cash position of -288.99 million or -5.17 per share.
| Cash & Cash Equivalents | 387.38M |
| Total Debt | 676.37M |
| Net Cash | -288.99M |
| Net Cash Per Share | -5.17 |
| Equity (Book Value) | 1.11B |
| Book Value Per Share | 17.69 |
| Working Capital | 308.45M |
Cash Flow
In the last 12 months, operating cash flow was 55.34 million and capital expenditures -47.74 million, giving a free cash flow of 7.60 million.
| Operating Cash Flow | 55.34M |
| Capital Expenditures | -47.74M |
| Depreciation & Amortization | 60.41M |
| Net Borrowing | -26.18M |
| Free Cash Flow | 7.60M |
| FCF Per Share | 0.14 |
Margins
Gross margin is 35.60%, with operating and profit margins of -5.18% and -4.05%.
| Gross Margin | 35.60% |
| Operating Margin | -5.18% |
| Pretax Margin | -5.41% |
| Profit Margin | -4.05% |
| EBITDA Margin | 3.86% |
| EBIT Margin | -5.18% |
| FCF Margin | 0.90% |
Dividends & Yields
TPEX:6677 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.25% |
| Shareholder Yield | -2.25% |
| Earnings Yield | -3.23% |
| FCF Yield | 0.72% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 1, 2021. It was a forward split with a ratio of 1.05.
| Last Split Date | Nov 1, 2021 |
| Split Type | Forward |
| Split Ratio | 1.05 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |